Lumexa Imaging (NASDAQ:LMRI) Director Brett Brodnax Buys 35,000 Shares

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) Director Brett Brodnax acquired 35,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 19th. The shares were acquired at an average cost of $7.25 per share, with a total value of $253,750.00. Following the purchase, the director owned 62,027 shares in the company, valued at $449,695.75. This represents a 129.50% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Lumexa Imaging Price Performance

Shares of LMRI opened at $8.18 on Friday. Lumexa Imaging Holdings, Inc. has a 52-week low of $6.45 and a 52-week high of $19.45. The business has a fifty day moving average of $9.75.

Analyst Ratings Changes

A number of research analysts recently commented on LMRI shares. Raymond James Financial upgraded Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price objective on the stock in a report on Monday, February 9th. Barclays dropped their price target on shares of Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a research report on Wednesday. Finally, Weiss Ratings began coverage on shares of Lumexa Imaging in a research report on Wednesday, May 13th. They set a “sell (e-)” rating for the company. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $16.00.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in LMRI. Assetmark Inc. acquired a new stake in shares of Lumexa Imaging in the 4th quarter valued at about $36,000. Strs Ohio purchased a new stake in Lumexa Imaging in the first quarter valued at approximately $38,000. PNC Financial Services Group Inc. acquired a new position in shares of Lumexa Imaging in the 1st quarter valued at $63,000. State of Wyoming purchased a new stake in Lumexa Imaging in the 1st quarter valued at $91,000. Finally, Barclays PLC purchased a new position in Lumexa Imaging during the 4th quarter worth $133,000.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).